Senior Research Associate High Throughput Cellular Pharmacology
Boston, MA - USA
Job Summary
Monte Rosa Therapeutics is seeking a motivated HighThroughput Ceelular Assasy expert to contribute to our mission of eliminating disease-causing proteins through targeted protein degradation an innovative approach that enables us to target proteins once considered undruggable. The ideal candidate will have strong expertise in developing high-throughput cellular assays for screening and compound profiling. You will join a fast-paced and innovative team environment that values teamwork collaboration and scientific rigor.
- Culture a variety of cell lines and primary cells to develop and optimize high-throughput cellular assays to evaluate target engagement degradation and pathway modulation
- Utilize automation system to execute cell-based screening and profiling campaigns
- Collaborate within a matrixed environment that integrates multiple functions to drive program decisions.
- Keep meticulous records of experiments on ELN.
- MS or Ph.D. with inMolecular Biology Biochemistry Biology orrelatedfield.
- The Senior Research Associate II level will have 4-6 years of relevent industrial experience and a Scientist wiill pocess 1-2 years industrial exerience
- A thorough understanding of assay principles is required
- Hands-on experience developing and executing cellular assays for lead discovery and optimization is required. Relevant assay formats include NanoBRET cellular HTRF AlphaLISA HiBiT and NanoBiT Degradation Kinetics.
- Experience working in a drug discovery environmentis preferred.
- Experience with compound screening formats laboratory instrumentation and automation data analysis and management ispreferred.
- Strong collaborative mindset with the ability to thrive in a team-oriented setting.
- Ability to adapt effectively to rapidly approaching deadlines in a dynamic research environment.
- Excellentoral and written communication skills.
Required Experience:
Senior IC
About Company
Pioneering Therapies for Cancer and Beyond – Our drug discovery platform is tailored to promote specific protein ubiquitination and subsequent proteasomal degradation of disease-causing, undruggable proteins, in essence leading to pharmacological protein knockout with high efficiency ... View more